Wednesday, October 10, 2018

With safety and cash at stake, a squabble over drug compounding puts the FDA in a bind

WASHINGTON — It’s been five years since Congress gave FDA sweeping authority to regulate compounding, but lawmakers — many of ...
Post a Comment